Dosimetry for treatment with radiolabelled somatostatin analogues. A review
Dosimetry for treatment with radiolabelled somatostatin analogues. A review
About this item
Full title
Author / Creator
Cremonesi, M , Botta, F , Di Dia, A , Ferrari, M , Bodei, L , De Cicco, C , Rossi, A , Bartolomei, M , Mei, R , Severi, S , Salvatori, M , Pedroli, G and Paganelli, G
Publisher
Italy: Edizioni Minerva Medica
Journal title
Language
English
Formats
Publication information
Publisher
Italy: Edizioni Minerva Medica
Subjects
More information
Scope and Contents
Contents
Peptide Receptor Radionuclide Therapy (PRRT) has proven its efficacy in the treatment of neuroendocrine and other somatostatin receptor expressing tumours (SR-tumours). Several clinical trials have confirmed that adverse effects are represented by possible renal impairment, which is the major concern, and low but not absent hematological toxicity....
Alternative Titles
Full title
Dosimetry for treatment with radiolabelled somatostatin analogues. A review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733085483
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733085483
Other Identifiers
ISSN
1824-4785
E-ISSN
1827-1936
